Product
FDA022
1 clinical trial
1 indication
Indication
CancerClinical trial
A PhaseⅠStudy to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of FDA022-BB05 in Subjects With Advanced Solid Malignant TumorsStatus: Not yet recruiting, Estimated PCD: 2024-03-01